Mexico Benefits from US Healthcare Confustion

By USABR

With the US healthcare market poised for turmoil as Congress wrestles with Obamacare and out-of-control costs, US firms are now looking to invest in Mexico, according to Luis Garduno, Managing Director at the healthcare M + A advisory firm, VERTESS.

“US citizens are already flocking to Mexico for cosmetic surgery, dental care, elective surgery, fertility treatments, cardiovascular surgery, and therapeutic recovery,” says Garduno. “Mexico also enjoys lower interest rates and taxes, making the Mexican healthcare market and attractive alternatives to investing in the US.”

While working in the finance industry in Mexico City for the past 25 years, providing financial support and advice to industry leaders such as Johnson & Johnson, Garduno has witnessed first-hand the maturing of the Mexican healthcare market.

“My experience with companies in the pharmaceutical, medical equipment manufacturing, home care/hospice, and health service provider markets tells me that there’s never been a better time for US firms to invest,” says Garduno.

However, he also warns that companies thinking of investing will need expertise on corporate governance, tax strategies, M + A initiatives, and due diligence processes that are specific to the Mexican market. “The opportunities are there, providing you know what you’re doing,” he says.

In addition to his extensive industry experience, Luis recently completed credentialing to become a Certified Merger and Acquisition Advisor (CMAA) through the international Alliance of Merger and Acquisitions Advisors (AMAA).

“I am looking forward to helping companies navigate the very dynamic healthcare market in Mexico,” says Garduno. “This is a growing market with tremendous opportunities for American buyers and investors.”